- Home
- TAK vs VALE Comparison
TAK vs VALE Comparison
Compare TAK & VALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | VALE |
|---|---|---|
| Founded | 1781 | 1942 |
| Country | Japan | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1B | 60.3B |
| IPO Year | 2007 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TAK | VALE |
|---|---|---|
| Price | $17.38 | $13.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $16.96 |
| AVG Volume (30 Days) | 4.0M | ★ 21.5M |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | 3.24% | ★ 5.71% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.16 | N/A |
| Revenue Next Year | $1.22 | N/A |
| P/E Ratio | $41.25 | ★ $29.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $9.67 |
| 52 Week High | $18.90 | $17.94 |
Technical Indicators
Market Signals| Indicator | TAK | VALE |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 35.73 |
| Support Level | $16.15 | $12.51 |
| Resistance Level | $17.83 | $15.20 |
| Average True Range (ATR) | 0.25 | 0.32 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 71.24 | 6.43 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About VALE VALE S.A.
Vale is a large global miner and the world's largest producer of iron ore and pellets. In recent years the company has sold noncore assets such as its fertilizer, coal, and steel operations to concentrate on iron ore, nickel, and copper. Earnings are dominated by its iron ore business. The base metals division is much smaller, consisting of nickel mines and smelters along with copper mines producing copper in concentrate. In 2024, Vale sold a minority 10% stake in its base metals business, likely the first step in separating base metals and iron ore.